AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Secured Loans | ₹1,159 Cr | ₹2,135 Cr | ₹619 Cr | ₹249 Cr | ₹168 Cr |
What is the latest Secured Loans ratio of AUROBINDO PHARMA ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹1,159 Cr |
| Mar2024 | ₹2,135 Cr |
| Mar2023 | ₹619 Cr |
| Mar2022 | ₹249 Cr |
| Mar2021 | ₹168 Cr |
How is Secured Loans of AUROBINDO PHARMA Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,159 Cr | -45.69 | |
| Mar2024 | ₹2,135 Cr | 244.92 | |
| Mar2023 | ₹619 Cr | 148.37 | |
| Mar2022 | ₹249 Cr | 47.91 | |
| Mar2021 | ₹168 Cr | - | |
Compare Secured Loans of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹87,680.5 Cr | 1.4% | 12.7% | 28.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,032.0 Cr | 0.9% | 12.8% | 4.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,759.0 Cr | 3.2% | 14% | 13.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,224.0 Cr | 0.7% | 5.5% | 36.9% | Stock Analytics | |
| CIPLA | ₹116,214.0 Cr | 6.8% | 18.8% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,739.0 Cr | 0.7% | 5.5% | 9.4% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 1.4% |
12.7% |
28.7% |
| SENSEX | -3.1% |
-2.8% |
-6.1% |
You may also like the below Video Courses